A growing number of European nations are suspending use of the AstraZeneca COVID vaccine, one of three on the continent, after reports of blood clots and other problems among a small number of people. AstraZeneca says these are isolated cases. Dr. Kirsten Bibbins-Domingo, chair of epidemiology and biostatistics at the University of California, San Francisco, joins William Brangham to discuss.
Stream your PBS favorites with the PBS app: [ Ссылка ]
Find more from PBS NewsHour at [ Ссылка ]
Subscribe to our YouTube channel: [ Ссылка ]
Follow us:
Facebook: [ Ссылка ]
Twitter: [ Ссылка ]
Instagram: [ Ссылка ]
Subscribe:
PBS NewsHour podcasts: [ Ссылка ]
Newsletters: [ Ссылка ]
Ещё видео!